ArticlePharmaceutics2026

Short-Term Metabolic and Inflammatory Effects of Upadacitinib in Biologic-Refractory Spondyloarthritis: Real-World Evidence on Lipid Paradox and Safety.

Zeynel Abidin Akar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.